Try it
Anaesthesia · Pharmacology: remimazolam
Sample itemWhat is a distinguishing feature of remimazolam?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. An ultra-short-acting benzodiazepine metabolised by tissue esterases and reversible with flumazenil
Remimazolam is a benzodiazepine designed with an ester linkage, so tissue esterases rapidly convert it to an inactive metabolite. This gives fast onset and offset, making it suitable for procedural sedation and general anaesthesia. Its effects are reversed by flumazenil.
Option by option
A. An alpha-2 agonist metabolised by the kidney
Dexmedetomidine is an alpha-2 agonist.
B. An opioid with context-insensitive half-time
Remifentanil is the opioid with context-insensitive characteristics.
C. A barbiturate with long duration
It is a benzodiazepine, not a barbiturate.
D. An ultra-short-acting benzodiazepine metabolised by tissue esterases and reversible with flumazenil (correct)
Correct. Ester metabolism gives it ultra-short action while flumazenil can still reverse it.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Anaesthesia questions
- Intravenous anaestheticsWhich intravenous anaesthetic agent typically increases heart rate and blood pressure?
- Regional anaesthesiaWhat is the definitive treatment for persistent post-dural puncture headache that does n…
- Inhalational anaestheticsWhich of the following inhalational agents has the lowest MAC, and so the highest potency?
- Pre-operative assessmentA patient with well-controlled mild hypertension and no functional limitation is classif…